Search

everythinglearnresearchcommunity

for

Search:↓

Keratin 17 is modified by RSK1 in response to growth and stress, affecting skin growth and stress response.

New therapies are being developed that target integrin pathways to treat various diseases.

PPARγ is essential for maintaining healthy skin, controlling inflammation, and ensuring proper skin barrier function.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Treatments that reduce oxidative stress and fix mitochondrial problems may help heal chronic wounds.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

PRP therapy may effectively treat hair loss, but more research needed.

Small molecule drugs show promise for advancing regenerative medicine but still face development challenges.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

Feather patterns form through genetic and epigenetic controls, with cells self-organizing into periodic patterns.

Keratin 18 helps diagnose and predict cancer progression and affects cancer growth and spread.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Interleukin-1 increases keratin K6 production in skin cells.

A new mutation in the hairless gene causes hair loss and skin wrinkling in mice.

HO-1 helps skin health and healing but can worsen melanoma; it's a potential treatment target for skin diseases.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

Gray hair can potentially be reversed, leading to new treatments.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Understanding hair growth involves complex interactions between molecules and could help treat hair disorders.

Cannabinoids may help treat various skin conditions.

Genomic approach finds new possible treatments for hair loss.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Certain genes are more active in baby scalp cells and can help grow hair when added to adult mouse skin cells.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Metabolic Syndrome is linked to several skin conditions, and stem cell therapy might help treat them.

Good feather growth in poultry needs the right balance of proteins, amino acids, minerals, and vitamins.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.